Filing Details

Accession Number:
0001677687-20-000001
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-08-25 11:03:03
Reporting Period:
2017-04-17
Accepted Time:
2020-08-25 11:03:03
Original Submission Date:
2017-06-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1502152 Angiosoma Inc. SOAN Pharmaceutical Preparations (2834) 273480481
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1677687 K Alex Blankenship 2500 Wilcrest Dr
Ste 300
Houston TX 77042
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-04-17 500,000 $0.00 500,000 No 4 P Direct
Common Stock Acquisiton 2017-07-19 2,000,000 $2,000.00 2,500,000 No 4 P Direct
Common Stock Acquisiton 2018-12-06 3,500,000 $0.00 6,000,000 No 4 P Direct
Common Stock Acquisiton 2020-08-14 5,000,000 $500.00 11,000,000 No 4 P Direct
Series E Preferred Stock Acquisiton 2016-08-11 1,000,000 $1,000.00 1,000,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The shares were issued pursuant to the Issuer's 2012 Stock Plan for Directors, Officers, and Consultants that has been registered with the SEC on Form S-8.
  2. Issued for services rendered.